Potential effect of ezetimibe againstMycobacterium tuberculosisinfection in type II diabetes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential effect of ezetimibe againstMycobacterium tuberculosisinfection in type II diabetes
Authors
Keywords
-
Journal
RESPIROLOGY
Volume 22, Issue 3, Pages 559-566
Publisher
Wiley
Online
2016-11-24
DOI
10.1111/resp.12948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin, Calcium Channel Blocker and Beta Blocker Therapy May Decrease the Incidence of Tuberculosis Infection in Elderly Taiwanese Patients with Type 2 Diabetes
- (2015) Mei-Yueh Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium’s Metabolism Is Constrained by the Intracellular Environment
- (2015) Brian C. VanderVen et al. PLoS Pathogens
- Ezetimibe suppresses cholesterol accumulation in lipid-loaded vascular smooth muscle cells in vitro via MAPK signaling
- (2014) Li Qin et al. ACTA PHARMACOLOGICA SINICA
- Diabetes and immunity to tuberculosis
- (2014) Nuria Martinez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The effects of statin use on the development of tuberculosis among patients with diabetes mellitus
- (2014) Y. A. Kang et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
- (2014) C. Skerry et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diabetes and Risk of Tuberculosis Relapse: Nationwide Nested Case-Control Study
- (2014) Pin-Hui Lee et al. PLoS One
- Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival ofMycobacterium tuberculosison fatty acids
- (2014) Hyungjin Eoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin as adjunct antituberculosis therapy
- (2014) A. Singhal et al. Science Translational Medicine
- Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus
- (2014) Blanca I. Restrepo et al. TUBERCULOSIS
- Inhibition of Niemann-Pick-type C1-like1 by ezetimibe activates autophagy in human hepatocytes and reduces mutant α1-antitrypsin Z deposition
- (2013) Takeshi Yamamura et al. HEPATOLOGY
- IntracellularMycobacterium tuberculosisExploits Host-derived Fatty Acids to Limit Metabolic Stress
- (2013) Wonsik Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
- (2013) Suraj P. Parihar et al. JOURNAL OF INFECTIOUS DISEASES
- The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells
- (2013) Helena Gbelcová et al. Lipids in Health and Disease
- Aminopeptidase N facilitates entry and intracellular survival ofMycobacterium tuberculosisin monocytes
- (2013) Hsin-Tsung Ho et al. RESPIROLOGY
- Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity
- (2012) Gregory W. Martens et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Editorial: Lipids: fueling the fire in tuberculosis?
- (2012) Vishwa Deep Dixit JOURNAL OF LEUKOCYTE BIOLOGY
- Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis
- (2011) Hugues Ouellet et al. TRENDS IN MICROBIOLOGY
- Mycobacterium tuberculosis Uses Host Triacylglycerol to Accumulate Lipid Droplets and Acquires a Dormancy-Like Phenotype in Lipid-Loaded Macrophages
- (2011) Jaiyanth Daniel et al. PLoS Pathogens
- Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years
- (2010) Eirini Lioudaki et al. Current Vascular Pharmacology
- Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
- (2010) Mi-Jeong Kim et al. EMBO Molecular Medicine
- Triacylglycerol Utilization Is Required for Regrowth of In Vitro Hypoxic Nonreplicating Mycobacterium bovis Bacillus Calmette-Guerin
- (2009) K. L. Low et al. JOURNAL OF BACTERIOLOGY
- Mycobacterium tuberculosis Is Able To Accumulate and Utilize Cholesterol
- (2009) A. Brzostek et al. JOURNAL OF BACTERIOLOGY
- Mycobacterium tuberculosis Rv3802c Encodes a Phospholipase/Thioesterase and Is Inhibited by the Antimycobacterial Agent Tetrahydrolipstatin
- (2009) Sarah K. Parker et al. PLoS One
- Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus
- (2008) Jeremy P. Mauldin et al. CIRCULATION
- Hypercholesterolemia Impairs Immunity to Tuberculosis
- (2008) G. W. Martens et al. INFECTION AND IMMUNITY
- Cholesterol Accumulation by Macrophages Impairs Phagosome Maturation
- (2008) Kassidy K. Huynh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials
- (2008) A. Pandor et al. JOURNAL OF INTERNAL MEDICINE
- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
- (2008) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mycobacterial persistence requires the utilization of host cholesterol
- (2008) A. K. Pandey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies
- (2008) Christie Y Jeon et al. PLOS MEDICINE
- Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence
- (2008) Pascale Peyron et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More